Shares of Utah Medical Products, Inc. (UTMD) have declined 3% since the company reported its earnings for the quarter ended June 30, 2025. This compares to the S&P 500 index's 0.6% growth over the same time frame. Over the past month, the stock has declined 1.6% compared with the S&P 500's 3.4% growth. For the second quarter, Utah Medical reported earnings per share (EPS) of 94 cents, representing a 4% decline from 98 cents in the second quarter of 2024. Net sales of $10 million marked a 4.3% decrease from ...